Molecular pharmacology of hallucinogens.
D000661:Amphetamine / Q000633:toxicity; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D003216:Conditioning, Operant / Q000187:drug effects; D004644:Emotions / Q000187:drug effects; D006213:Hallucinogens / Q000494:pharmacology*; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008550:Melatonin / Q000378:metabolism; D008635:Mescaline / Q000378:metabolism; D008715:Methionine / Q000494:pharmacology; D008722:Methods; D008956:Models, Chemical; D011605:Psychoses, Substance-Induced / Q000209:etiology; D011618:Psychotic Disorders / Q000209:etiology; D051381:Rats; D011930:Reaction Time / Q000187:drug effects; D012559:Schizophrenia / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D013312:Stress, Physiological; D014363:Tryptamines / Q000494:pharmacology
D006213:Hallucinogens; D014363:Tryptamines; D012701:Serotonin; D008238:Lysergic Acid Diethylamide; D008715:Methionine; D000661:Amphetamine; D008550:Melatonin; D008635:Mescaline